Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | KCNQ2 | O43526 | 3/20 | 0.52 |
| ▸ | CRHBP | P24387 | 2/20 | 0.52 |
| ▸ | CRHR2 | Q13324 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | KDM4A | O75164 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.49 |
| ▸ | HDAC4 | P56524 | 3/20 | 0.49 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.49 |
| ▸ | HDAC7 | Q8WUI4 | 3/20 | 0.49 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.49 |
| ▸ | HDAC10 | Q969S8 | 3/20 | 0.49 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pheneturide SCHEMBL35066 | 0.87 | ALDH1A1 (0.56) | ALDH1A1POLBKCNQ2CRHBPCRHR2 | |
| SCHEMBL15553366 | 0.83 | CRHBP (0.52) | ALDH1A1POLBCRHBPCRHR2KDM4A | |
| SCHEMBL15552462 | 0.83 | CRHBP (0.52) | ALDH1A1POLBCRHBPCRHR2KDM4A | |
| Hydrochloric Acid SCHEMBL15559323 | 0.83 | EPHX1 (0.41) | ALDH1A1POLBKCNQ2CRHBPCRHR2 | |
| SCHEMBL15554309 | 0.83 | CRHBP (0.52) | ALDH1A1POLBCRHBPCRHR2KDM4A | |
| SCHEMBL15553655 | 0.83 | EPHX1 (0.63) | ALDH1A1POLBHTTSMN1; SMN2KDM4A | |
| SCHEMBL15555286 | 0.83 | EPHX1 (0.63) | ALDH1A1POLBHTTSMN1; SMN2KDM4A | |
| SCHEMBL15554157 | 0.83 | EPHX1 (0.63) | ALDH1A1POLBHTTSMN1; SMN2KDM4A | |
| Hydrochloric Acid SCHEMBL15559325 | 0.82 | CRHBP (0.51) | ALDH1A1POLBCRHBPCRHR2KDM4A | |
| Hydrochloric Acid SCHEMBL15554159 | 0.81 | EPHX1 (0.61) | ALDH1A1POLBHTTSMN1; SMN2KDM4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240082161-A1 | STABILIZATION OF PHENOBARBITAL SODIUM FOR INJECTION | SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED (IN) | 2024-03-14 | — | — | US | claimed |
| US-11878076-B2 | Lyophilized compositions of phenobarbital sodium salt | Nivagen Pharmaceuticals, Inc. (US) | 2024-01-23 | — | — | US | claimed |
| US-11857683-B2 | Stabilization of phenobarbital sodium for injection | SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED (IN) | 2024-01-02 | — | — | US | claimed |
| US-20230157959-A1 | Lyophilized Compositions of Phenobarbital Sodium Salt | Nivagen Pharmaceuticals, Inc. (US) | 2023-05-25 | — | — | US | claimed |
| US-20230031957-A1 | STABILIZATION OF PHENOBARBITAL SODIUM FOR INJECTION | SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED (IN) | 2023-02-02 | — | — | US | claimed |
| US-20220354794-A1 | Lyophilized Compositions of Phenobarbital Sodium Salt | Nivagen Pharmaceuticals, Inc. (US) | 2022-11-10 | — | — | US | claimed |
| US-11406598-B2 | Lyophilized compositions of phenobarbital sodium salt | Nivagen Pharmaceuticals, Inc. (US) | 2022-08-09 | — | — | US | claimed |
| US-20210085608-A1 | Lyophilized Compositions of Phenobarbital Sodium Salt | Nivagen Pharmaceuticals, Inc. (US) | 2021-03-25 | — | — | US | claimed |
| US-20240082161-A1 | STABILIZATION OF PHENOBARBITAL SODIUM FOR INJECTION | SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED (IN) | 2024-03-14 | — | — | US | disclosed |
| US-11878076-B2 | Lyophilized compositions of phenobarbital sodium salt | Nivagen Pharmaceuticals, Inc. (US) | 2024-01-23 | — | — | US | disclosed |
| US-11878076-B2 | Lyophilized compositions of phenobarbital sodium salt | Nivagen Pharmaceuticals, Inc. (US) | 2024-01-23 | — | — | US | disclosed |
| US-11857683-B2 | Stabilization of phenobarbital sodium for injection | SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED (IN) | 2024-01-02 | — | — | US | disclosed |
| US-11857683-B2 | Stabilization of phenobarbital sodium for injection | SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED (IN) | 2024-01-02 | — | — | US | disclosed |
| WO-2023175542-A1 | STABILIZATION OF PHENOBARBITAL SODIUM FOR INJECTION | SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED (IN) | 2023-09-21 | — | — | WO | disclosed |
| US-11406598-B2 | Lyophilized compositions of phenobarbital sodium salt | Nivagen Pharmaceuticals, Inc. (US) | 2022-08-09 | — | — | US | disclosed |
| US-11406598-B2 | Lyophilized compositions of phenobarbital sodium salt | Nivagen Pharmaceuticals, Inc. (US) | 2022-08-09 | — | — | US | disclosed |
| US-20210085608-A1 | Lyophilized Compositions of Phenobarbital Sodium Salt | Nivagen Pharmaceuticals, Inc. (US) | 2021-03-25 | — | — | US | disclosed |
| US-20210085608-A1 | Lyophilized Compositions of Phenobarbital Sodium Salt | Nivagen Pharmaceuticals, Inc. (US) | 2021-03-25 | — | — | US | disclosed |
| US-9901576-B2 | Stable formulation of phenobarbital sodium injection | WEST-WARD PHARMACEUTICALS INTERNATIONAL LIMITED (GB) | 2018-02-27 | — | — | US | disclosed |
| US-20170143719-A1 | STABLE FORMULATION OF PHENOBARBITAL SODIUM INJECTION | HIKMA PHARMACEUTICALS USA INC. | 2017-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240082161-A1 | STABILIZATION OF PHENOBARBITAL SODIUM FOR INJECTION | PYGB, EPM2A, CACNA1A | ALDH1A1 388/4885POLB 1005/4885KCNQ2 111/4885 |
| US-20170143719-A1 | STABLE FORMULATION OF PHENOBARBITAL SODIUM INJECTION | F12, CPS1, PLPBP | ALDH1A1 572/4885POLB 378/4885KCNQ2 3339/4885 |
| US-20230031957-A1 | STABILIZATION OF PHENOBARBITAL SODIUM FOR INJECTION | EPM2A, PYGB, ATP6V1B2 | ALDH1A1 256/4885POLB 1254/4885KCNQ2 147/4885 |
| US-11857683-B2 | Stabilization of phenobarbital sodium for injection | EPM2A, PYGB, ATP6V1B2 | ALDH1A1 256/4885POLB 1254/4885KCNQ2 147/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.